Huntington National Bank Supernus Pharmaceuticals, Inc. Transaction History

Huntington National Bank

$13.8 Billion
Q4 2024

A detailed history of Huntington National Bank transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Huntington National Bank holds 778 shares of SUPN stock, worth $25,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares

778

Previous 746 4.29%

Holding current value

$25,020

Previous $23,000 21.74%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$31.89 - $37.83 $1,020 - $1,210	32 Added 4.29%	778 $28,000
Q3 2024 Nov 06, 2024	SELL	$25.77 - $35.16 $51 - $70	-2 Reduced 0.27%	746 $23,000
Q2 2024 Aug 08, 2024	SELL	$25.99 - $33.85 $311 - $406	-12 Reduced 1.58%	748 $20,000
Q1 2024 May 03, 2024	BUY	$27.11 - $35.17 $3,171 - $4,114	117 Added 18.2%	760 $25,000
Q4 2023 Feb 07, 2024	BUY	$22.72 - $29.68 $45 - $59	2 Added 0.31%	643 $18,000
Q3 2023 Nov 08, 2023	SELL	$27.57 - $32.91 $992 - $1,184	-36 Reduced 5.32%	641 $17,000
Q2 2023 Aug 11, 2023	SELL	$29.91 - $38.73 $358 - $464	-12 Reduced 1.74%	677 $20,000
Q1 2023 May 10, 2023	SELL	$34.93 - $42.03 $454 - $546	-13 Reduced 1.85%	689 $24,000
Q4 2022 Feb 09, 2023	SELL	$31.09 - $37.88 $3,482 - $4,242	-112 Reduced 13.76%	702 $25,000
Q2 2022 Aug 09, 2022	BUY	$25.33 - $34.25 $14,108 - $19,077	557 Added 216.73%	814 $24,000
Q4 2021 Jan 21, 2022	BUY	$26.37 - $34.22 $2,241 - $2,908	85 Added 49.42%	257 $7,000
Q2 2020 Jul 30, 2020	SELL	$17.09 - $24.89 $7,878 - $11,474	-461 Reduced 72.83%	172 $4,000
Q1 2020 Apr 27, 2020	BUY	$14.45 - $24.69 $3,540 - $6,049	245 Added 63.14%	633 $11,000
Q4 2019 Jan 17, 2020	SELL	$19.93 - $29.13 $1,654 - $2,417	-83 Reduced 17.62%	388 $9,000
Q2 2019 Jul 23, 2019	SELL	$29.96 - $38.87 $120,259 - $156,024	-4,014 Reduced 89.5%	471 $16,000
Q1 2019 Apr 09, 2019	BUY	$32.77 - $41.99 $131,997 - $169,135	4,028 Added 881.4%	4,485 $157,000
Q4 2018 Jan 28, 2019	BUY	$30.84 - $49.51 $4,965 - $7,971	161 Added 54.39%	457 $15,000
Q3 2018 Oct 18, 2018	SELL	$42.7 - $56.55 $33,861 - $44,844	-793 Reduced 72.82%	296 $15,000
Q2 2018 Jul 19, 2018	SELL	$44.1 - $59.85 $573 - $778	-13 Reduced 1.18%	1,089 $65,000
Q1 2018 Apr 30, 2018	BUY	$37.15 - $46.9 $33,732 - $42,585	908 Added 468.04%	1,102 $50,000
Q4 2017 Feb 02, 2018	SELL	$36.4 - $42.6 $837 - $979	-23 Reduced 10.6%	194 $8,000
Q3 2017 Oct 24, 2017	BUY	$36.75 - $49.65 $7,974 - $10,774	217	217 $9,000

Others Institutions Holding SUPN

# of Institutions

303

Shares Held

60.7M

Call Options Held

22.3K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.72B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Supernus Pharmaceuticals, Inc. Transaction History